Ad
related to: pathophysiology of hypokalemia treatment- About PH1
Discover an FDA-approved treatment
for patients with PH1.
- Dosing & Administration
See dosage and administration info
for an available PH1 treatment.
- Fill Out the Start Form
Fill out the Start Form to get
access to therapy.
- Patient Brochure
Help your patients
understand their condition.
- About PH1
Search results
Results From The WOW.Com Content Network
Hypokalemia which is recurrent or resistant to treatment may be amenable to a potassium-sparing diuretic, such as amiloride, triamterene, spironolactone, or eplerenone. Concomitant hypomagnesemia will inhibit potassium replacement, as magnesium is a cofactor for potassium uptake.
Low potassium is caused by increased excretion of potassium, decreased consumption of potassium rich foods, movement of potassium into the cells, or certain endocrine diseases. [3] Excretion is the most common cause of hypokalemia and can be caused by diuretic use, metabolic acidosis , diabetic ketoacidosis , hyperaldosteronism , and renal ...
The effect is an electrolyte imbalance similar to that seen with thiazide diuretic therapy (which causes pharmacological inhibition of NCC activity). [ 4 ] Gitelman syndrome was formerly considered a subset of Bartter syndrome until the distinct genetic and molecular bases of these disorders were identified.
Hypokalemic periodic paralysis is a condition that causes episodes of extreme muscle weakness typically beginning in childhood or adolescence. Most often, these episodes involve a temporary inability to move muscles in the arms and legs. Attacks cause severe weakness or paralysis that usually lasts from hours to days.
Hypertension, hypokalemia, metabolic alkalosis, and low plasma renin activity. [ 1 ] Apparent mineralocorticoid excess is an autosomal recessive [ 2 ] disorder causing hypertension (high blood pressure ), hypernatremia (increased blood sodium concentration) and hypokalemia (decreased blood potassium concentration).
Bartter syndrome (BS) is a rare inherited disease characterised by a defect in the thick ascending limb of the loop of Henle, which results in low potassium levels (hypokalemia), [2] increased blood pH , and normal to low blood pressure. There are two types of Bartter syndrome: neonatal and classic.
Secondary hyperaldosteronism (also hyperreninism, or hyperreninemic hyperaldosteronism) is due to overactivity of the renin–angiotensin–aldosterone system (RAAS).. The causes of secondary hyperaldosteronism are accessory renal veins, fibromuscular dysplasia, reninoma, renal tubular acidosis, nutcracker syndrome, ectopic tumors, massive ascites, left ventricular failure, and cor pulmonale.
Hypokalemia (low blood potassium concentration) often follows treatment. This increases the risk of dangerous irregularities in the heart rate . Therefore, continuous observation of the heart rate is recommended, [ 6 ] [ 39 ] as well as repeated measurement of the potassium levels and addition of potassium to the intravenous fluids once levels ...